April 6, 2024 — Experts from the Smidt Heart Institute at Cedars-Sinai will share new research and participate in more than 70 discussions during theÂ
April 5, 2024 — Johnson & Johnson and Shockwave Medical, Inc. today announced that they have entered into a definitive agreement under which Johnson & Johnson will acquire all outstanding shares of Shockwave for $335.00 per share in cash, corresponding to an enterprise value of approximately $13.1 billion including cash acquired. The transaction was approved by both companies’ boards of directors.
April 4, 2024 — Viz.ai, a leader in AI-powered disease detection and intelligent care coordination, announced new clinical data supporting advancements in cardiology care.
April 4, 2024 — A new study found increased coronary vessel wall thickness that was significantly associated with impaired diastolic function in asymptomatic, middle-aged individuals living with HIV.